Metformin vs active control
Serious adverse events ( · preventing the progression of CKD
Metformin showed no clear difference in serious adverse events ( compared with active control (moderate certainty).
1 finding from 1 review
- Metformin for preventing the progression of chronic kidney disease 2024 · Cochrane Headline outcomes onlyRR 1.16 [0.79, 1.71]2 studies · 5545 participantsModerate